Development progress

CarryGenes’ research efforts span several areas related to chromosome-based immunotherapies:

Using multiple CARs to prevent tumor immune escape.

CD34: A marker for sorting transfected cells.

Chemokine Receptors: Enabling cellular homing to tumors.

Safety Switch: A dual mechanism that promotes either cell survival or death, depending on the situation.

Cell Growth Factors: Enhancing cell activation and proliferation.

Additionally, CarryGenes has developed a comprehensive library of vectors, reagents and experimental tools to support future development.

‍

By using our website, you hereby consent to our disclaimer and agree to its terms